Long Focus Capital Management, LLC Standard Biotools Inc. Transaction History
Long Focus Capital Management, LLC
- $2.17 Billion
- Q2 2025
A detailed history of Long Focus Capital Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 10,070,000 shares of LAB stock, worth $13.3 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
10,070,000
Previous 6,700,000
50.3%
Holding current value
$13.3 Million
Previous $7.24 Million
67.0%
% of portfolio
0.56%
Previous 0.25%
Shares
2 transactions
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Casdin Capital, LLC New York, NY76.1MShares$100 Million12.8% of portfolio
-
Viking Global Investors LP58.7MShares$77.4 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$22.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.44MShares$9.82 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $104M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...